Clinical Trial
doi: 10.1016/0014-2964(75)90173-5.
A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma
- PMID: 767111
- DOI: 10.1016/0014-2964(75)90173-5
Item in Clipboard
Clinical Trial
A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma
Eur J Cancer (1965).
1975 Nov.
No abstract available
Similar articles
-
Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.Oncology. 1975;31(5-6):288-92. doi: 10.1159/000225035. Oncology. 1975. PMID: 174040
-
CCNU-adriamycin therapy in bronchogenic carcinoma.Cancer. 1978 May;41(5):1704-9. doi: 10.1002/1097-0142(197805)41:5<1704::aid-cncr2820410508>3.0.co;2-e. Cancer. 1978. PMID: 206337
-
Preliminary report on the use of CCNU (NSC-79037), adriamycin (NSC-123127), and hexamethylmelamine (NSC-13875) in carcinoma of the lung.Cancer Treat Rep. 1976 Mar;60(3):269-71. Cancer Treat Rep. 1976. PMID: 816467 Clinical Trial. No abstract available.
-
Monochemotherapy of bronchogenic carcinoma withs special reference to cell type.Cancer Chemother Rep 3. 1973 Mar;4(2):177-88. Cancer Chemother Rep 3. 1973. PMID: 4277763 Review. No abstract available.
-
Clinical comparison of the nitrosoureas.Cancer. 1975 Oct;36(4):1258-68. doi: 10.1002/1097-0142(197510)36:4<1258::aid-cncr2820360411>3.0.co;2-6. Cancer. 1975. PMID: 1100221 Review.